ArticleOncotarget2018

Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancer.

Kiley A Knapp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.